LUPINNSELupin Limited· PharmaceuticalsMediumNeutral
Announced Tue, 20 May · 08:43 IST

Lupin Limited has informed the Exchange regarding Change in Director(s) of the company.

Management Changes View source PDF

LUPIN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Lupin Limited announced two board changes approved on May 19, 2025. Mr. Kanwar Bir Singh Anand, former Managing Director and CEO of Asian Paints, has been re-appointed as an Independent Director for a second 5-year term from August 12, 2025 to August 11, 2030, subject to shareholder approval. Dr. Punita Kumar-Sinha's 5-year term as Independent Director ends on August 11, 2025, and she has chosen not to seek re-appointment; she will, however, stay on as an advisor until November 11, 2025 to help with transition. The Board recorded its appreciation for Dr. Sinha's contributions during her tenure. The re-appointment of Mr. Anand needs to be approved by shareholders at the upcoming general meeting.

Likely market impact

Routine board refresh with no red flags — one independent director is being retained for continuity while another steps down after completing a full term. Shareholders should see this as standard governance activity with no material impact on operations or stock price, though the re-appointment will require their vote.